[18F]LY4214835

LY4214835 · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for [18F]LY4214835, covering 2026-04-17 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer [Phase 1]